Literature DB >> 10146943

Routine childhood immunisation: is it worth it?

S P Conway1, B Leese.   

Abstract

Mesh：

Year:  1993        PMID： 10146943     DOI： 10.2165/00019053-199303030-00002

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  51 in total

Review 1.  Rubella reinfection.

Authors:  E Miller
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

2.  The costs of preventing measles.

Authors:  R D Nassau
Journal:  JAMA       Date:  1992-02-05       Impact factor: 56.272

3.  SSPE in the developing world.

Authors: 
Journal:  Lancet       Date:  1990-09-08       Impact factor: 79.321

Review 4.  BCG vaccination of schoolchildren in England and Wales.

Authors:  V H Springett; I Sutherland
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

5.  Permanent brain damage and pertussis vaccination: is the end of the saga in sight?

Authors:  A H Griffith
Journal:  Vaccine       Date:  1989-06       Impact factor: 3.641

6.  Screening hospital employees for measles immunity is more cost effective than blind immunization.

Authors:  J A Sellick; D Longbine; R Schifeling; J M Mylotte
Journal:  Ann Intern Med       Date:  1992-06-15       Impact factor: 25.391

7.  Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule.

Authors:  R Booy; S A Taylor; S R Dobson; D Isaacs; G Sleight; S Aitken; H Griffiths; H Chapel; R T Mayon-White; J A Macfarlane
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

8.  Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs.

Authors:  A R Hinman; J P Koplan
Journal:  JAMA       Date:  1984-06-15       Impact factor: 56.272

9.  Rubella in Panama: still a problem.

Authors:  C Saad de Owens; R Tristan de Espino
Journal:  Pediatr Infect Dis J       Date:  1989-02       Impact factor: 2.129

10.  Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children.

Authors:  C L Cody; L J Baraff; J D Cherry; S M Marcy; C R Manclark
Journal:  Pediatrics       Date:  1981-11       Impact factor: 7.124
View more
  3 in total

Review 1.  Costs, innovation and efficiency in anti-infective therapy.

Authors:  J L Bootman; R J Milne
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

Review 2.  Hepatitis B vaccine: a pharmacoeconomic evaluation of its use in the prevention of hepatitis B virus infection.

Authors:  S M Holliday; D Faulds
Journal:  Pharmacoeconomics       Date:  1994-02       Impact factor: 4.981

Review 3.  A cellular pertussis vaccine (Infanrix-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection.

Authors:  S S Patel; A J Wagstaff
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.